Related Experiment Videos
Taskforce 5: preimplantation genetic diagnosis.
F Shenfield1, G Pennings, P Devroey
1Reproductive Medicine Unit, Obstetric Hospital, 2nd Floor, University College Hospital, Huntley Street, London WC1 6AU, UK. mfi@easynet.co.uk
Human Reproduction (Oxford, England)
|March 5, 2003
Summary
The European Society of Human Reproduction and Embryology (ESHRE) Ethics Task Force recommends a multidisciplinary approach for preimplantation genetic diagnosis (PGD). This guidance covers ethical principles, high genetic risk cases, and PGD applications like aneuploidy screening and sex selection.
Area of Science:
- Reproductive Medicine
- Medical Ethics
- Genetics
Background:
- Preimplantation genetic diagnosis (PGD) is a rapidly evolving technology.
- Ethical considerations are paramount in its application.
- ESHRE provides guidance on reproductive technologies.
Framework:
- Recommends a multidisciplinary approach to PGD.
- Addresses fundamental ethical principles relevant to PGD.
- Outlines considerations for high genetic risk cases.
Implementation:
- Covers PGD for aneuploidy screening.
- Includes PGD for HLA typing.
- Addresses PGD for non-medical sex selection.
Implications:
- Aims to guide ethical and responsible PGD implementation.
- Facilitates informed decision-making for patients and clinicians.
- Contributes to the evolving landscape of reproductive genetics and ethics.
Keywords:
Genetics and Reproduction